These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4592459)

  • 1. [Biological determination of antimicrobials with Escherichia coli].
    Rappe A
    Ann Pharm Fr; 1973 Jun; 31(6):435-40. PubMed ID: 4592459
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of trimethoprim on Escherichia coli under limited nutrition.
    Then R; Angehrn P
    Arzneimittelforschung; 1973 Mar; 23(3):451-5. PubMed ID: 4575178
    [No Abstract]   [Full Text] [Related]  

  • 3. Nature of trimethoprim-induced death in Escherichia coli.
    Angehrn P; Then R
    Arzneimittelforschung; 1973 Mar; 23(3):447-51. PubMed ID: 4575177
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible causes of leucine inhibition in Escherichia coli K12 lambda-28.
    Horváth I; Gadó I
    Acta Microbiol Acad Sci Hung; 1965; 12(1):103-7. PubMed ID: 4952939
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibacterial properties of some 2,7-dihydrofuro[3,4-d]pyrimidines.
    Pluta J; Flendrich M; Cieplik J; Królicki ZA
    Acta Pol Pharm; 1994; 51(1):55-8. PubMed ID: 7976435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of purine and pyrimidine derivatives on prophage induction in Escherichia coli C600 T44].
    Noack D; Klaus S
    Z Allg Mikrobiol; 1972; 12(7):583-91. PubMed ID: 4576648
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel and efficient one step synthesis of 2-amino-5-cyano-6-hydroxy-4-aryl pyrimidines and their anti-bacterial activity.
    Deshmukh MB; Salunkhe SM; Patil DR; Anbhule PV
    Eur J Med Chem; 2009 Jun; 44(6):2651-4. PubMed ID: 19036478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing incidence of resistance of Escherichia coli to antimicrobials.
    Gedebou M; Tassew A
    Ethiop Med J; 1983 Apr; 21(2):61-9. PubMed ID: 6343076
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation on the antibacterial properties of some 5-pyrimidinecarboxylic acid derivatives.
    Cieplik J; Pluta J; Flendrich M
    Acta Pol Pharm; 1994; 51(1):59-62. PubMed ID: 7976436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergism of trimethoprim-sulfamethoxazole association].
    Pechère JC
    Pathol Biol (Paris); 1971; 19(11):621-6. PubMed ID: 4933626
    [No Abstract]   [Full Text] [Related]  

  • 11. 7-Ribosyl-3-deazaguanine--mechanism of antibacterial action.
    Streeter DG; Miller M; Matthews TR; Robins RK; Miller JP
    Biochem Pharmacol; 1980 Jun; 29(12):1791-7. PubMed ID: 6996683
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro susceptibility of Escherichia coli of swine origin to carbadox and other antimicrobials.
    Das NK
    Am J Vet Res; 1984 Feb; 45(2):252-4. PubMed ID: 6370050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the usage volume of veterinary therapeutic antimicrobials and resistance in Escherichia coli isolated from the feces of food-producing animals in Japan.
    Asai T; Kojima A; Harada K; Ishihara K; Takahashi T; Tamura Y
    Jpn J Infect Dis; 2005 Dec; 58(6):369-72. PubMed ID: 16377870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3-Dimethylpyrimidoheterocycles as antibacterial agents.
    Zoorob HH; Abou Elzahab M; Abdel-Mogib M; Ismail MA; Abdel-Hamid M
    Arzneimittelforschung; 1997 Aug; 47(8):958-62. PubMed ID: 9296283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental data on the antibacterial effect of the combination sulfadoxine-trimethoprim].
    Böhni E
    Berl Munch Tierarztl Wochenschr; 1971 Mar; 84(5):87-91. PubMed ID: 4994550
    [No Abstract]   [Full Text] [Related]  

  • 17. Organoiodine (III) mediated synthesis of 3-aryl/hetryl-5,7-dimethyl-1,2,4-triazolo[4,3-a]pyrimidines as antibacterial agents.
    Prakash O; Bhardwaj V; Kumar R; Tyagi P; Aneja KR
    Eur J Med Chem; 2004 Dec; 39(12):1073-7. PubMed ID: 15571869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul].
    Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A
    Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility testing of pathogenic Escherichia coli using non-standard conditions.
    Ring DL; Flournoy DJ
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):139-42. PubMed ID: 6379344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition of a biotinless mutant of Escherichia coli by purines and pyrimidines.
    BERGER M; LARDY HA
    Proc Soc Exp Biol Med; 1954 Jan; 85(1):89-93. PubMed ID: 13134299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.